Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control Mouthwash
← catalyst calendarSponsored by Colgate Palmolive (industry) · CL — their whole pipeline →.
Phase
Phase 3
Status
Completed
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
80actual
Sites
1
Country
Italy
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-12-01 | actual | When the study began enrolling |
| Primary completion | 2026-02-27 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-02-27 | actual | The whole study's end, after follow-up |
| First posted | 2025-12-04 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-26 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Gingivitis
- Plaque, Dental
Interventions
- Drug: cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash
- Drug: sodium fluoride Mouthwash
Primary outcomes
what the primary-completion date above is the date OFModified Gingival Index
measured baseline, 2 week, 6 week & 3 month
Saxton Bleeding Index
measured baseline, 2 week, 6 week & 3 month
Modified Quigley-Hein Plaque Index
measured baseline, 2 week, 6 week & 3 month
Permalink · CL's whole pipeline · Catalyst calendar · Every registered study · What changed